Anderson Veterinary Orthopaedic Consultancy Limited

Contents

Abridged Balance Sheet	1
Notes to the Unaudited Abridged Financial Statements	2 to 3

Anderson Veterinary Orthopaedic Consultancy Limited

(Registration number: 10877249)
Abridged Balance Sheet as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Other financial assets	4	2,689,305	2,696,823
Current assets
Debtors		4,719	-
Cash at bank and in hand		155,678	226,495
		160,397	226,495
Creditors: Amounts falling due within one year		(2,607,292)	(2,682,856)
Net current liabilities		(2,446,895)	(2,456,361)
Net assets		242,410	240,462
Capital and reserves
Called up share capital		100	100
Other reserves		167,391	240,362
Profit and loss account		74,919	-
Total equity		242,410	240,462

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
	The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 8 December 2025
 

Mrs L S Anderson

Director

Anderson Veterinary Orthopaedic Consultancy Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Old House
Northcote Lane
Shamley Green
Guildford
Surrey
GU5 0RB

These financial statements were authorised for issue by the director on 8 December 2025.

2	Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The director has considered the financial position of the company in view of the results in the period ended 31 March 2025. The company's ability to continue trading is reliant on the director continuing to support the company through their director's loan account. The director has agreed not to seek repayment of the amounts owed within 12 months of the date of the accounts where this would affect the company's ability to trade.

The director has considered a period of 12 months from the date of approval of the financial statements and considers it appropriate to prepare the financial statements on the going concern basis.

Prior period errors

Income from investments not included in operating profit in the previous year

	Relating to the current period disclosed in these financial statements £	Relating to the prior period disclosed in these financial statements £	Relating to periods before the prior period disclosed in these financial statements £
Operating profit	-	107,847	-

Revenue recognition

Turnover represents a combination of interest and dividends received from the holding of investments in conjunction with the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Page 2

Anderson Veterinary Orthopaedic Consultancy Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in the profit or loss account. Investments in equity shares where fair value cannot be measured reliably are measured at cost less impairment.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

4	Other financial assets (current and non-current)

	Financial assets at fair value through profit and loss £	Total £
Non-current financial assets
Cost or valuation
At 1 April 2024	2,696,823	2,696,823
Fair value adjustments	(47,599)	(47,599)
Additions	395,058	395,058
Disposals	(354,977)	(354,977)
At 31 March 2025	2,689,305	2,689,305
Carrying amount
At 31 March 2025	2,689,305	2,689,305
At 31 March 2024	2,696,823	2,696,823